摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

furfuryl-quinazolin-4-yl-amine | 34116-16-0

中文名称
——
中文别名
——
英文名称
furfuryl-quinazolin-4-yl-amine
英文别名
N-(furan-2-ylmethyl)quinazolin-4-amine
furfuryl-quinazolin-4-yl-amine化学式
CAS
34116-16-0
化学式
C13H11N3O
mdl
MFCD02069202
分子量
225.25
InChiKey
DUNCYLVJORGPHP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.076
  • 拓扑面积:
    51
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    碘乙烷furfuryl-quinazolin-4-yl-amine 在 sodium hydride 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 6.0h, 生成
    参考文献:
    名称:
    Fabrication of Furan-Functionalized Quinazoline Hybrids: Their Antibacterial Evaluation, Quantitative Proteomics, and Induced Phytopathogen Morphological Variation Studies
    摘要:
    The limited number of agrochemicals targeting plant bacterial diseases has driven us to develop highly efficient, low-cost, and versatile antibacterial alternatives. Herein, a novel type of simple furan-functionalized quinazolin-4-amines was systematically fabricated and screened for their antibacterial activity. Bioassay results revealed that compounds C-1 and E-4 could substantially block the growth of two frequently mentioned pathogens Xanthomonas oryzae pv oryzae and X. axonopodis pv citri in vitro, displaying appreciable EC50 values of 7.13 and 10.3 mg/L, respectively. This effect was prominently improved by comparing those of mainly used agrochemicals. An in vivo experiment against bacterial blight further illustrated their viable applications as antimicrobial ingredients. Quantitative proteomics demonstrated that C-1 possessed a remarkable ability to manipulate the upregulation and downregulation of expressed proteins, which probably involved D-glucose and biotin metabolic pathways. This finding was substantially verified by parallel reaction monitoring analysis. Scanning electron microscopy images and fluorescence spectra also indicated that the designed compounds had versatile capacities for destroying the integrity of bacteria. Given these remarkable characteristics, furan-functionalized quinazoline hybrids can serve as a viable platform for developing innovative antibiotic alternatives against bacterial infections.
    DOI:
    10.1021/acs.jafc.9b03419
  • 作为产物:
    描述:
    4-氯喹唑啉2-呋喃甲胺 在 potassium fluoride 作用下, 以 为溶剂, 反应 17.0h, 以71%的产率得到furfuryl-quinazolin-4-yl-amine
    参考文献:
    名称:
    杂芳基氯化物的胺化:绿色溶剂中的钯催化或 SNAr?
    摘要:
    嘧啶、吡嗪和喹唑啉系列中的杂芳基氯化物与水中的胺在 KF 存在下发生反应,导致容易的 S N Ar 反应和N芳基化。除非存在额外的吸电子基团,否则吡啶的反应不太令人满意。结果表明,无过渡金属的 S N Ar 反应不仅优于钯催化的偶联反应,而且在碱和溶剂方面也可以在环境可接受的(“绿色”)条件下进行。
    DOI:
    10.1002/cssc.201300239
点击查看最新优质反应信息

文献信息

  • Amination of Heteroaryl Chlorides: Palladium Catalysis or S<sub>N</sub>Ar in Green Solvents?
    作者:Katie Walsh、Helen F. Sneddon、Christopher J. Moody
    DOI:10.1002/cssc.201300239
    日期:2013.8
    reaction of heteroaryl chlorides in the pyrimidine, pyrazine and quinazoline series with amines in water in the presence of KF results in a facile SNAr reaction and N‐arylation. The reaction is less satisfactory with pyridines unless an additional electron‐withdrawing group is present. The results showed that the transition‐metal‐free SNAr reaction not only compares favourably to palladium‐catalysed
    嘧啶、吡嗪和喹唑啉系列中的杂芳基氯化物与水中的胺在 KF 存在下发生反应,导致容易的 S N Ar 反应和N芳基化。除非存在额外的吸电子基团,否则吡啶的反应不太令人满意。结果表明,无过渡金属的 S N Ar 反应不仅优于钯催化的偶联反应,而且在碱和溶剂方面也可以在环境可接受的(“绿色”)条件下进行。
  • GIRGIS N. S.; MZHUSTOLLER J.; REDERSEN E. V., CHEM. SCR., 26,(1986) N 4, 617-621
    作者:GIRGIS N. S.、 MZHUSTOLLER J.、 REDERSEN E. V.
    DOI:——
    日期:——
  • Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof
    申请人:Yuan Junying
    公开号:US20120258975A1
    公开(公告)日:2012-10-11
    Certain aspects of the invention relates to small molecule autophagy inhibitors of the formula (I), and their use for treatment and prevention of cancers and acute pancreatitis. As disclosed herein, a small molecule inhibitor of autophagy was been identified from an image-based screen in a known bioactive library. It was found that this autophagy inhibitor functions by promoting the degradation of type III PI3 kinase complex which is required for initiating autophagy. Medicinal chemistry studies led to small molecular autophagy inhibitors with improved potency and selectivity. (I)
  • Fabrication of Furan-Functionalized Quinazoline Hybrids: Their Antibacterial Evaluation, Quantitative Proteomics, and Induced Phytopathogen Morphological Variation Studies
    作者:Qing-Su Long、Li-Wei Liu、Yong-Liang Zhao、Pei-Yi Wang、Biao Chen、Zhong Li、Song Yang
    DOI:10.1021/acs.jafc.9b03419
    日期:2019.10.9
    The limited number of agrochemicals targeting plant bacterial diseases has driven us to develop highly efficient, low-cost, and versatile antibacterial alternatives. Herein, a novel type of simple furan-functionalized quinazolin-4-amines was systematically fabricated and screened for their antibacterial activity. Bioassay results revealed that compounds C-1 and E-4 could substantially block the growth of two frequently mentioned pathogens Xanthomonas oryzae pv oryzae and X. axonopodis pv citri in vitro, displaying appreciable EC50 values of 7.13 and 10.3 mg/L, respectively. This effect was prominently improved by comparing those of mainly used agrochemicals. An in vivo experiment against bacterial blight further illustrated their viable applications as antimicrobial ingredients. Quantitative proteomics demonstrated that C-1 possessed a remarkable ability to manipulate the upregulation and downregulation of expressed proteins, which probably involved D-glucose and biotin metabolic pathways. This finding was substantially verified by parallel reaction monitoring analysis. Scanning electron microscopy images and fluorescence spectra also indicated that the designed compounds had versatile capacities for destroying the integrity of bacteria. Given these remarkable characteristics, furan-functionalized quinazoline hybrids can serve as a viable platform for developing innovative antibiotic alternatives against bacterial infections.
查看更多